New chief business officer for Corium
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph Sarret, corium
Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer.
Chinese government to lift drug price controls
May 5, 2015Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government
The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
Bayer buys blood-thinning drug from Isis
May 5, 2015Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning
German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …
Worldwide cancer spending tops $100 billion
May 5, 2015Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology
Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …
Novo Nordisk invests in haemophilia with Denmark facility
May 5, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven
Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …
Working Life: AstraZeneca’s Jonathan Day
May 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Jonathan Day, Working Life
How did you find your way into your current role? By way of background, I trained in medicine at the …
Two consultants join RSA’s UK team
May 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agata Grzeszczuk, Andy Theodorou, rsa
Life sciences recruitment firm RSA has appointed two new consultants to its UK executive search team. Agata Grzeszczuk (pictured) takes …
Takeda pays $2.7 billion to settle Actos lawsuits
May 1, 2015Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2
Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …
Martindale Pharma expands business in Asia-Pacific
May 1, 2015Manufacturing and Production, Sales and Marketing Singapore, aft pharma, martindale
UK-based speciality firm Martindale Pharma is to expand its business in the Asia-Pacific market with the appointment of AFT Pharmaceuticals …
GSK sees FDA clearance for asthma drug
May 1, 2015Sales and Marketing Breo Ellipta, FDA, GSK, Theravance
GlaxoSmithKline and Theravance’s Breo Ellipta inhaler has been approved by the FDA to treat asthma in adults. Whilst the once-daily treatment …
Virgo Consumer Health & Wellbeing hires associate director
May 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kirsty McKinnon, Virgo
Virgo Consumer Health & Wellbeing has appointed Kirsty McKinnon to lead the division’s personal care sector. McKinnon joins the firm …
Profits fall at Bayer but new drugs see growth
May 1, 2015Sales and Marketing Bayer, Eliquis, Eylea, Renegeron, Xarelto, apixaban
Bayer’s pharmaceutical revenues have continued their upward trajectory in the first quarter of 2015 thanks to new products, although this …
Apple research apps to require ethics board approval
April 30, 2015Sales and Marketing Apple, BMJ, FDA, GP, researchkit
New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …
Perrigo bats away raised Mylan bid
April 30, 2015Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger
Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …
NHS ‘close to breaking point’
April 30, 2015Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund
England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …
FDA waves through generic BMS antipsychotic
April 30, 2015Manufacturing and Production, Sales and Marketing Alembic, BMS, FDA, Hetero and Torrent Pharmaceuticals, Teva
The FDA has approved four generic versions of Bristol-Myers Squibb’s top selling Abilify, an atypical antipsychotic drug approved to treat …
Recipharm appoints general manager for Italian unit
April 30, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Giorgio Bruno, Recipharm
Contract development and manufacturing organisation Recipharm has confirmed that Dr Giorgio Bruno has been appointed general manager of Recipharm Italia. In …
Pharma accused of hiding behind regulation and undermining NICE
April 29, 2015Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma
University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …
Pfizer posts second consecutive quarterly income decline
April 29, 2015Sales and Marketing 2015, Pfizer, Q1, first quarter
Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …
Merck sales fall in Q1 despite new product lifts
April 29, 2015Sales and Marketing Merck, Q1, Remicade
Merck’s sales were down in the first quarter of 2015 thanks to its consumer care divestment and increasing competition for …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
